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Key Messages
1. SARS coronavirus has 
low transmissibility at the 
community level.
2. Subclinical SARS coronavirus 
infection is rare in children.
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Introduction
SARS was a newly emerged infectious disease, and its aetiology was attributed 
to a novel coronavirus, SARS coronavirus (SARS-CoV). Hong Kong was one 
of the most severely affected areas, with a total of 1755 local residents infected 
and 302 fatalities.1 Children, in contrast to adults, had less severe disease and 
paediatric SARS constituted only 6.9% of the total number of SARS cases in 
Hong Kong. The territory-wide age-specific attack rate was 8.9 cases per 100 000 
persons aged younger than 18 years compared to 30.0 cases per 100 000 adults.2 
Similar findings were also noted in Taiwan, where only 7.2% of SARS patients 
were 20 years or younger.3 Reviews on clinical features, investigations, and 
prognostic indicators on paediatric SARS in Hong Kong have been published, 
however there is a lack of data on possible asymptomatic infection in children at 
the community level. Since clinical SARS in children was mild, whether there 
were more subclinical infections in this age-group was unanswered.
 Our objective was to determine the seroprevalence of SARS-CoV among 
asymptomatic children aged 6 to 15 years from three large housing estates 
around the Amoy Gardens, where a superspreading event giving rise to 330 
cases occurred. We also set out to obtain comparative data from a paediatric 
sample, living in a low-risk housing estate with no SARS case in that different 
district.
Methods
This study was conducted from September to October 2003.
Study design
Risk-stratified seroprevalence study of children under 15 years old, living in a 
high-risk area where large community outbreaks had occurred (Amoy Gardens, 
Ngau Tau Kok Estates, and Telford Gardens), was compared with those living 
in a low-risk area (Wah Fu Estate). Subjects were approached and recruited via 
primary and secondary schools in the two areas.
Sample size
A total of 353 children living in the high-risk area and 361 living in the low-risk 
area were recruited.
Study instruments
Using a standardised questionnaire, the information collected included: socio-
demographic data, history of SARS infection in the subjects and members 
of the household. Questions were also directed at any history of contact with 
known cases of SARS, presence of SARS-like symptoms since March 2003, 
travel history of the child and his/her relatives within 15 days prior to any such 
symptom onset, use of health services as a result of such symptoms, and whether 
there were deaths of relatives as a result of SARS. Parents of all the subjects who 
joined the study were contacted by telephone, and the above questionnaire was 
administered by a trained research nurse.
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 SARS-CoV immunoglobulin G (IgG) antibody testing 
was performed on all subjects. Immunofluorescence assay 
was performed and any positive results were confirmed by 
a virus neutralisation test.
Results
Subject characteristics stratified by risk categories are 
shown in the Table. The SARS-CoV infection rate in the 
high-risk area was >70 per 1000 persons, whereas that in the 
low-risk area was 0.1-0.4 per 1000 persons. The high- and 
low-risk areas had similar population densities; the number 
of residents below the age of 15 years was 10 340 per km2 
and 9498 per km2, respectively. The sex ratios of children in 
the two groups were similar. None of the subjects in either 
group reported a previous history of SARS. Two (0.6%) 
of 353 children from the high-risk area were found to be 
seropositive for SARS-CoV antibody (95% confidence 
interval [CI], 0.07-2.0%). Both had been completely 
asymptomatic of any SARS-like illness since March 2003 
until the current test. All 361 children in the low-risk area 
were seronegative (seroprevalence=0%; 95% CI, 0-1.0%). 
The difference in seropositivity rates between high-risk and 
low-risk areas were not statistically different (P=0.24).
 In the high-risk group, 11 (3.1%) children had close 
family members diagnosed with SARS that included one 
who died, while none of the family members of children 
in the control group had SARS (P=0.002). Three other 
children (0.8%) had a history of contact with persons who 
were diagnosed to have SARS outside the household. All 
14 of these children who had known SARS contacts were 
seronegative for SARS-CoV. None of the children in the 
control group had a positive contact history.
 More children (20.5%) in the low-risk area reported 
having symptoms during the SARS epidemic compared 
to the high-risk group (12.2%) [P=0.004]. Chills (9.4%) 
and cough (4.7%) occurred significantly more commonly 
in children from the low-risk group compared to the high-
risk group (4.8% had chills [P=0.03] and 1.1% had cough 
[P=0.01]). Overall reported rates of respiratory symptoms 
were lower in the high-risk group.
Discussion
Much progress has been made in characterising the 
clinicopathological features and epidemiology of SARS 
in the 2 years since its emergence. A review of its clinical 
features in adults and children showed that there were two 
major differences between adult and paediatric SARS 
patients: (1) the incidence in children was substantially 
lower than in adults, and (2) SARS was much milder in 
children and none aged less than 18 years died anywhere 
in the world.4 The present study was the first community-
based seroepidemiological survey in children. The key 
question concerns whether asymptomatic infection with 
SARS-CoV represented another end of disease spectrum 
in children, and if so, whether the potential caseload was 
significant enough to constitute a source for spread in the 
community.
 The fact that paediatric patients affected by SARS 
had a relatively mild clinical course led some to postulate 
that children might have only mild symptoms or remain 
asymptomatic after being infected by SARS-CoV. Such 
patients might never present to the health care system and 
could thus explain the apparently lower incidence of SARS 
in the paediatric population. Our study showed that within a 
Characteristic High-risk area (n=353) Low-risk area (n=361) P value
Sex
Male 187 (53.0%) 173 (47.9%) 0.18
Female 166 (47.0%) 188 (52.1%)
Mean (SD) age (years) 10.5 (2.3) 10.5 (2.4) 0.97
Housing type
Private housing 132 (37.4%) 128 (35.5%) 0.65
Public housing 221 (62.6%) 233 (64.5%)
SARS-CoV immunoglobulin G
Positive 2 (0.6%) 0 0.24
Any household member diagnosed to have SARS 11 (3.1%) 0 0.002
Any SARS contact outside household 3 (0.8%) 0 0.24
Any relative(s) died of SARS 1 (0.3%) 0 0.99
Presence of clinical symptoms
Yes 43 (12.2%) 74 (20.5%) 0.004
Fever 28 (7.9%) 28 (7.8%) 1.00
Chills 17 (4.8%) 34 (9.4%) 0.03
Cough 4 (1.1%) 17 (4.7%) 0.01
Shortness of breath 1 (0.3%) 2 (0.6%) 1.00
Headache 4 (1.1%) 8 (2.2%) 0.40
Generalised malaise 5 (1.4%) 5 (1.4%) 1.00
Diarrhoea 3 (0.8%) 5 (1.4%) 0.75
Medical consultation because of clinical symptoms 40/43 (93.0%) 60/74 (81.1%) 0.14
Still went to school despite having above symptoms 10/43 (23.3%) 36/74 (48.6%) 0.01
Table.	 Subject	characteristics
Seroprevalence of SARS-CoV in outbreak and low-risk areas
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geographic area where superspreading events had occurred, 
positive serology for SARS-CoV in healthy asymptomatic 
children was also very uncommon (0.57%); the difference 
in rates between the respective areas was not statistically 
significant. Only two cases of asymptomatic infection with 
SARS-CoV were documented in our study. ‘Subclinical’ 
SARS, as revealed by positive anti-SARS CoV IgG in 
asymptomatic individuals, has been consistently found to be 
an uncommon entity across different seroepidemiological 
surveys in both hospital and community settings. A 
systematic review5 of SARS-CoV seroprevalence studies 
showed that the overall seroprevalence in asymptomatic 
population groups was 0.1% (95% CI, 0.02-0.018%). The 
seroprevalence in high-risk groups such as health care 
workers and close contacts of SARS patients was only 
slightly higher (0.23%; 95% CI, 0-0.37%) than the overall 
seroprevalence. The study concluded that seroconversion 
was an extremely rare event in individuals who did not 
develop SARS, and SARS-CoV infection almost certainly 
led to clinically apparent disease which in the majority of 
patients was of great severity warranting hospitalisation 
during the 2003 epidemic. In a study on SARS-CoV 
seroprevalence in close contacts of all SARS patients in 
Hong Kong, only two (0.19%) were seropositive, and one 
of them was a 4-year-old boy who lived with his parents 
and grandfather who all had SARS.6 In fact, when restricted 
to close contacts of SARS cases from Amoy Gardens, the 
seroprevalence in that study was 0.62% (1/161), which was 
virtually identical to our present estimate (P=0.99).
 Although symptoms of SARS in children were more 
non-specific, the majority of patients could be reliably 
identified by vigilant frontline health care professionals 
according to stringent diagnostic case definition criteria. 
The reported incidence of paediatric SARS from hospital 
cases very likely represents the true incidence of SARS in 
Hong Kong children. It was unlikely that subclinical SARS, 
with such a low prevalence, could have assumed a role in 
the spread of SARS within the community.
 There are several explanations for the low incidence 
of SARS in children from an epidemiological point of 
view. The SARS outbreak in Hong Kong first started in 
hospital settings and mostly involved health care workers 
and adult patients. There was no reported SARS outbreak 
in paediatric wards, and it has been routine practice in 
Hong Kong that children are not allowed to visit hospital 
wards, thereby limiting their risk of exposure during that 
critical period. The inherent transmissibility of SARS in the 
community setting was low, and this was further reduced by 
stringent public health measures including early admission 
of all suspected SARS cases to hospital, quarantine of 
Amoy Gardens Block E residents, school suspension, and 
reinforcement of strict environmental hygiene. In fact, the 
majority of SARS patients in Hong Kong were victims of 
point-source outbreaks at the Prince of Wales Hospital or 
Amoy Garden residential complex, and infection without 
a direct epidemiological link was uncommon. There 
was no spread of SARS in the school setting, despite 
many infected children having attended school until they 
developed symptoms of infection. Retrospectively, the risk 
of contracting the disease through casual contacts within 
the community was minimal.
 There are several limitations of this study. Young 
children aged less than 6 years were not included, as we 
only recruited our subjects by approaching primary and 
secondary schools in the two areas. A relatively low subject 
recruitment rate was another drawback. Difficulties were 
encountered when seeking consent from parents, probably 
due to reluctance with respect to blood-taking in young 
children, as well as less concerns about SARS after the 
epidemic. Recall and reporting bias about SARS-associated 
symptoms was also possible, as the questionnaire was 
administered several months after the peak of the SARS 
epidemic.
Conclusion
By determining the prevalence rate of SARS-CoV IgG 
antibody in children in both high-risk and low-risk 
residential areas, our study confirmed previous observations 
that SARS-CoV had low transmissibility at that community 
level, and subclinical SARS-CoV infection was rare in 
children. This community-based serological survey also 
indicated that SARS-CoV was transmitted in very specific 
settings, and that its spread could be effectively controlled 
by early detection and isolation of symptomatic patients. 
However, the low seroprevalence rate in the community 
means that the public will have little protection from herd 
immunity, should SARS re-emerge.
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